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Identity 
Other names: TEL (translocation ets leukemia) 
HGNC (Hugo): ETV6 
Location: 12p13.1 
 
ETV6 (12p13.1) in normal cells: clone dJ852F10 - Courtesy 
Mariano Rocchi, Resources for Molecular Cytogenetics. 
DNA/RNA 
Description 
A member of the ets (E-26 transforming specific) 
family of transcription factors; the gene spans a region 
of 240 kb and consists of 8 exons. 
Transcription 
Transcription is from telomere to centromere; there are  
three species of transcripts: 2400kb, 4300kb and 6200 
kb; the gene encodes for a 1356 kb cDNA. 
Protein 
Description 
There are two alternative start codons that 
correspondingly result in two isoforms. Codon 1 gives 
rise to a 57kDa protein while codon 43 gives rise to a 
53 kDa protein. It has been demonstrated that these two 
isoforms are phosphorylated.  ETV6 shares homology 
at the 5' and 3' ends with other ets family members, 
namely the helix-loop-helix (HLH) and ETS domains, 
respectively. HLH domain is encoded by exons 3 and 4 
and has also been referred to as the pointed or sterile 
alpha motif (SAM) domain. It is responsible for hetero- 
and homodimerization with other ETV6 proteins and 
possibly other ets family members. The ETS domain is 
encoded by exons 6 through 8 and is responsible for 
sequence specific DNA-binding. It is positively 
charged, allowing it to bind to purine rich segments of 
DNA. A central domain also exists that is involved in 
the recruitment of a repression complex including 
NCOR2 and SIN3. 
 
 












Expression arrays and Northern analysis have shown 
ubiquitous expression with greater expression in boe 
marrow, spleen and thymus. 
Localisation 
Immunofluorescence has shown a nuclear localization. 
Function 
Acts as a transcriptional regulator; important in 




ETV6 is implicated in leukemia, myelodysplastic 
syndromes and sarcoma. 
Implicated in 
t(1;12)(p36;p13) --> MDS2/ETV6 
Disease 
One CML with t(9;22) and one refractory anemia with 
excess of blasts in transformation. 
t(1;12)(q21;p13) --> ARNT/ETV6 
Disease 
AML-M2. 
t(1;12)(q25;p13) --> ABL2/ETV6 
Disease 
AML-M3, -M4, T-cell ALL. 
t(3;12)(q26;p13) --> EVI1/ETV6 
Disease 
CML. 
t(4;12) (p16;p13) --> FGFR3/ETV6 
Disease 
Peripheral T-cell lymphoma. 
t(4;12)(q11;p13) --> CHIC2 (BTL)/ETV6 
Disease 
AML (FAB type M0) 
t(5;12)(q31;p13) --> FACL6/ETV6 
Disease 
Acute myelogenous leukemia with eosinophilia. 
t(5;12)(q33;p13) --> PDGFRb/ETV6 
Disease 
CMML. 
t(6;12)(q23;p13) --> STL/ETV6 
Disease 
B-cell ALL. 
t(7;12)(q36;p13) --> HLXB9/ETV6 
Disease 
AML (FAB type M1). 
dic(9;12)(p13;p13) --> PAX5/ETV6 
Disease 
ALL. 
t(9;12) (p24;p13) --> JAK2/ETV6 
Disease 
Leukemias. 
t(9;12)(q22;p13) --> SYK/ETV6 
Disease 
MDS. 
t(9;12)(q34;p13) --> ABL1/ETV6 
Disease 
Acute myeloblastic leukemia (AML), chronic 
myelogenous leukemia (CML), acute lymphocytic 
leukemia (ALL). 
t(10;12)(q24;p13) --> ?/ETV6 
Disease 
CMML. 
t(12;13)(p13;q12) --> ETV6/CDX2 
Disease 
CML in transformation, myelodysplastic syndrome 
(MDS), acute non lymphocytic leukemai (ANLL), B 
and T- ALL. 
 






Atlas Genet Cytogenet Oncol Haematol. 2005; 9(4)  
 
274 
t(12;13)(p13;q14) --> ETV6/TTL 
Disease 
ALL. 
t(12;15)(p13;q25) --> ETV6/NTRK3 
Disease 
Congenital Fibrosarcoma, Congenital Mesoblastic 
Nephroma (cellular and mixed variants), Secretory 
Ductal Carcinoma of Breast, AML. 
 
 
t(12;17)(p13;p12-p13) --> ETV6/PER1 
Disease 
AML. 
t(12;21)(p13;q22) --> ETV6/AML1 
Disease 
Childhood B-cell (ALL). 
t(12;22)(p13;q11) --> ETV6/MN1 
Disease 
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